Among them, we identified fibronectin, insulin‐like growth factor‐binding protein 7 (IGFBP7) and tissue‐type plasminogen activator (PLAT), which are all glycoproteins intricately associated with cancer development and progression (Corte et al., 2005; Gibson et al., 2023; Godina et al., 2021; Haley & Freeman., 2018; Jin et al., 2020). This evidence concerns the gene IGFBP7 and cancer.